Found: 6
Select item for more details and to access through your institution.
The Use of Animal Neuropeptides in the Treatment of Neurological Diseases.
- Published in:
- Neuroscience & Behavioral Physiology, 2024, v. 54, n. 2, p. 205, doi. 10.1007/s11055-024-01586-x
- By:
- Publication type:
- Article
Drug Synergism as the Basis of Rational Neuroprotection.
- Published in:
- Neuroscience & Behavioral Physiology, 2022, v. 52, n. 8, p. 1207, doi. 10.1007/s11055-023-01349-0
- By:
- Publication type:
- Article
Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program
- Published in:
- Neuroscience & Behavioral Physiology, 2022, v. 52, n. 6, p. 836, doi. 10.1007/s11055-022-01307-2
- By:
- Publication type:
- Article
Direct and Indirect Neurological Signs of COVID-19.
- Published in:
- Neuroscience & Behavioral Physiology, 2021, v. 51, n. 7, p. 856, doi. 10.1007/s11055-021-01144-9
- By:
- Publication type:
- Article
SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies.
- Published in:
- Neuroscience & Behavioral Physiology, 2021, v. 51, n. 5, p. 577, doi. 10.1007/s11055-021-01108-z
- By:
- Publication type:
- Article
Selection of Neuroprotective Therapy in Patients with Chronic Cerebral Ischemia Taking Account of the Synergism of Drug Interactions.
- Published in:
- Neuroscience & Behavioral Physiology, 2021, v. 51, n. 4, p. 430, doi. 10.1007/s11055-021-01088-0
- By:
- Publication type:
- Article